Company Overview and News

 
Reliance Infrastructure Limited - Shareholders meeting

2018-09-18 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

 
RInfra AGM: Anil Ambani complains of slow arbitration award payouts

2018-09-18 livemint
Mumbai: Reliance Group chairman Anil Ambani today hit out at government agencies, which owe his debt-laden Reliance Infrastructure Ltd (RInfra) payouts awarded in arbitration.
500390 RELINFRA RELEY RIFS RIFA RELFF

 
Reliance Infrastructure Limited - News Clarification

2018-09-17 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

 
Reliance Infrastructure Limited - Press Release

2018-09-14 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

 
IDBI Bank moves NCLT against Reliance Naval’s ₹1,250 crore loan default

2018-09-06 livemint
Mumbai: IDBI Bank Ltd has approached the dedicated bankruptcy court against Reliance Naval and Engineering Ltd for defaulting on loans totaling more than ₹1,250 crore.
500390 RELINFRA 532662 500116 RELEY RIFS IDBI HTMEDIA RIFA RELFF

 
IDBI Bank files insolvency application against Reliance Naval in NCLT

2018-09-06 moneycontrol
IDBI Bank has filed an insolvency application in the National Company Law Tribunal (NCLT) seeking debt resolution of Reliance Naval and Engineering under the Insolvency and Bankruptcy Code (IBC).
500390 RELINFRA 500116 RELEY RIFS IDBI RIFA RELFF

 
Crisil withdraws D rating for RInfra NCDs

2018-09-05 moneycontrol
Reliance Infrastructure (RInfra) said rating agency Crisil has withdrawn its D rating for the company's non-convertible debentures totalling Rs 710 crore. "Crisil has withdrawn its 'D' ratings for Reliance Infrastructure's NCDs totalling Rs 710 crore.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

 
Muthoot Finance, Advanced Enzyme, Cyient, Reliance Infra top gainers among BSE #39;A#39; group stocks

2018-09-05 moneycontrol
The Indian market extended the morning losses in the afternoon with the Nifty50 trading at 11,455, down 65 points and the Sensex trading 210 points lower at 37,947.
MUTHOOTFIN RELEY CREST RIFS RELFF 517506 533398 500390 RELINFRA 532234 TTKPRESTIG 511413 RIFA NATIONALUM

 
Reliance Infrastructure gains 2% as CRISIL withdraws D rating for its NCDs worth Rs 710cr

2018-09-05 moneycontrol
Shares of Reliance Infrastructure added 2 percent intraday Wednesday after rating agency CRISIL withdrawn its D ratings for company's NCDs of totalling Rs 710 crore.
500390 RELINFRA RELEY RIFS 539254 RIFA RELFF ADANITRANS

 
Reliance Infrastructure Limited - Press Release

2018-09-05 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

 
RInfra consortium inks pact with MSRDC for 7,000 crore Versova-Bandra sea link project

2018-09-04 moneycontrol
Reliance Infrastructure (RInfra) said Tuesday that its consortium has inked an MoU with Maharashtra State Road Development Corporation (MSRDC) for the Rs 7,000-crore Versova-Bandra Sea Link Project in Mumbai.
500390 RELINFRA RELEY RIFS RIFA RELFF

 
Reliance Infrastructure Limited - Press Release

2018-09-04 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

 
Reliance Infrastructure Limited - Press Release

2018-09-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

 
Reliance Infrastructure wins Rs 200 crore arbitration against NHAI : Company

2018-09-03 moneycontrol
Reliance Infrastructure on Monday said it has won a Rs 200 crore arbitration award against National Highway Authority of India (NHAI).
500390 RELINFRA RELEY RIFS RIFA RELFF

 
Reliance Infrastructure Limited - Press Release

2018-09-03 nseindia
The information displayed herein is uploaded by the concerned Company. The said uploaded information is displayed without any verification of adequacy, accuracy and veracity. The Exchange in discharge of its role of dissemination of uploaded information on this website immediately on its receipt. The Company shall be solely responsible and liable for any omission, commission, errors and misrepresentations in the contents of the Information.
500390 RELINFRA RELEY RIFS RIFA RELFF

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...